Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles
Christine Rangger,1 Anna Helbok,1 Jane Sosabowski,2 Christian Kremser,3 Gottfried Koehler,4 Ruth Prassl,5,6 Fritz Andreae,7 Irene J Virgolini,1 Elisabeth von Guggenberg,1 Clemens Decristoforo11Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria; 2Centre for Molecular Onc...
Main Authors: | Rangger C, Helbok A, Sosabowski J, Kremser C, Koehler G, Prassl R, Andreae F, Virgolini IJ, von Guggenberg E, Decristoforo C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-12-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/tumor-targeting-and-imaging-with-dual-peptide-conjugated-multifunction-a15190 |
Similar Items
-
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
by: Rangger C, et al.
Published: (2012-11-01) -
Radiopharmaceutical Formulation and Preclinical Testing of <sup>68</sup>Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
by: Anton A. Hörmann, et al.
Published: (2021-06-01) -
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
by: Maximilian Klingler, et al.
Published: (2019-01-01) -
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. <i>Pharmaceuticals</i> 2019, <i>12</i>, 13
by: Maximilian Klingler, et al.
Published: (2019-06-01) -
Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression.
by: Dominik Summer, et al.
Published: (2018-01-01)